Rezolute (RZLT) Shares Outstanding (Weighted Average) (2010 - 2026)

Rezolute recorded quarterly Shares Outstanding (Weighted Average) of $103.7 million in Q1 2026, little changed quarter-over-quarter from $103.7 million in Q4 2025, and up 48.1% year-over-year from $70.0 million in Q1 2025.

Rezolute's Shares Outstanding (Weighted Average) history runs 17 years deep, the most recent figure standing at $103.7 million for Q1 2026.

  • In Q1 2026, Shares Outstanding (Weighted Average) rose 48.1% year-over-year to $103.7 million; the TTM figure through Mar 2026 stood at $103.7 million (up 48.1% YoY), while the FY2025 annual figure was $76.0 million, up 47.67% from the prior year.
  • Shares Outstanding (Weighted Average) came in at $103.7 million for Q1 2026 at Rezolute, roughly flat from $103.7 million in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $103.7 million in Q1 2026 to a low of $1.1 million in Q1 2023.
  • A 5-year average of $49.5 million and a median of $51.4 million in 2023 frame the typical range for Shares Outstanding (Weighted Average).
  • Across the five-year window, Shares Outstanding (Weighted Average) sank 93.48% in 2023 and surged 4464.31% in 2024, its largest moves.
  • Rezolute's Shares Outstanding (Weighted Average) stood at $51.4 million in 2022, then slipped by 0.0% to $51.4 million in 2023, then surged by 35.85% to $69.8 million in 2024, then jumped by 48.47% to $103.7 million in 2025, then rose by 0.03% to $103.7 million in 2026.
  • According to Business Quant data, Shares Outstanding (Weighted Average) over the past three periods registered $103.7 million, $103.7 million, and $103.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Weighted Avg.) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 177,333.76 Bn
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - 185,491.37 Bn
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 100.00 Bn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - 55.66 Bn
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 118.76 Bn
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 254.10 Mn
7 Evaxion A 62.56 Bn 62.54 Bn - 16.04 Bn
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 104.00 Mn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 132.89 Mn
10 Rezolute 374.41 Mn 374.41 Mn - 103.71 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 103.71 Mn
Dec 31, 2025 103.69 Mn
Sep 30, 2025 103.42 Mn
Jun 30, 2025 16.40 Mn
Mar 31, 2025 70.03 Mn
Dec 31, 2024 69.84 Mn
Sep 30, 2024 69.74 Mn
Jun 30, 2024 51.47 Mn
Mar 31, 2024 51.21 Mn
Dec 31, 2023 51.41 Mn
Sep 30, 2023 51.41 Mn
Jun 30, 2023 12.92 Mn
Mar 31, 2023 1.12 Mn
Dec 31, 2022 51.41 Mn
Sep 30, 2022 1.15 Mn
Jun 30, 2022 14.58 Mn
Mar 31, 2022 17.22 Mn
Dec 31, 2021 1.19 Mn
Sep 30, 2021 1.22 Mn
Jun 30, 2021 1.25 Mn
Mar 31, 2021 8.35 Mn
Dec 31, 2020 1.44 Mn
Sep 30, 2020 600,000.00
Jun 30, 2020 618,000.00
Mar 31, 2020 30.92 Mn
Dec 31, 2019 5,866.00
Sep 30, 2019 45.55 Mn
Jun 30, 2019 920,000.00
Mar 31, 2019 62,053.00
Dec 31, 2018 62,124.00
Sep 30, 2018 62,166.00
Jun 30, 2018 913.00
Mar 31, 2018 54.07 Mn
Dec 31, 2017 53.33 Mn
Sep 30, 2017 52.89 Mn
Jun 30, 2017 32,796.00
Mar 31, 2017 42.22 Mn
Dec 31, 2016 38.09 Mn
Sep 30, 2016 35.40 Mn
Jun 30, 2016 24.77 Mn
Mar 31, 2016 24.34 Mn
Dec 31, 2015 24.34 Mn
Sep 30, 2015 24.34 Mn
Jun 30, 2015 20.95 Mn
Mar 31, 2015 22.54 Mn
Dec 31, 2014 18.89 Mn
Sep 30, 2014 18.13 Mn
Jun 30, 2014 9.38 Mn
Mar 31, 2014 6.67 Mn
Dec 31, 2013 6.67 Mn
Sep 30, 2013 6.67 Mn
Jun 30, 2013 6.20 Mn
Mar 31, 2013 40.00 Mn
Dec 31, 2012 24.61 Mn
Sep 30, 2012 3.65 Mn
Jun 30, 2012 3.59 Mn
Mar 31, 2012 3.84 Mn
Dec 31, 2011 23.02 Mn
Sep 30, 2011 3.84 Mn
Jun 30, 2011 3.47 Mn
Mar 31, 2011 3.84 Mn
Dec 31, 2010 3.07 Mn
Sep 30, 2010 3.05 Mn